Terms: = Lung cancer AND ERC1, ELKS, 23085, ENSG00000082805, MGC12974, RAB6IP2, KIAA1081, Cast2, Q8IUD2, KIAA108 AND Treatment
3 results:
1. Successful Crizotinib-targeted Therapy of Pediatric Unresectable erc1::ALK Fusion Sarcoma.
Wood ML; Fanburg-Smith JC; Brian JM; White JC; Powell JL; Freiberg AS
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e184-e187. PubMed ID: 38099690
[TBL] [Abstract] [Full Text] [Related]
2. Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing.
Shi M; Wang W; Zhang J; Li B; Lv D; Wang D; Wang S; Cheng D; Ma T
Cancer Sci; 2022 Jan; 113(1):308-318. PubMed ID: 34710947
[TBL] [Abstract] [Full Text] [Related]
3. Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.
Zhou X; Shou J; Sheng J; Xu C; Ren S; Cai X; Chu Q; Wang W; Zhen Q; Zhou Y; Li W; Pan H; Li H; Sun T; Cheng H; Wang H; Lou F; Rao C; Cao S; Pan H; Fang Y
Cancer Sci; 2019 Oct; 110(10):3382-3390. PubMed ID: 31444835
[TBL] [Abstract] [Full Text] [Related]
